Meyer-Schuman Rebecca, Cale Allison R, Pierluissi Jennifer A, Jonatzke Kira E, Park Young N, Lenk Guy M, Oprescu Stephanie N, Grachtchouk Marina A, Dlugosz Andrzej A, Beg Asim A, Meisler Miriam H, Antonellis Anthony
Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.
Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
bioRxiv. 2024 Mar 27:2024.03.25.586600. doi: 10.1101/2024.03.25.586600.
Aminoacyl-tRNA synthetases (ARSs) are ubiquitously expressed, essential enzymes that complete the first step of protein translation: ligation of amino acids to cognate tRNAs. Genes encoding ARSs have been implicated in myriad dominant and recessive phenotypes, the latter often affecting multiple tissues but with frequent involvement of the central and peripheral nervous system, liver, and lungs. Threonyl-tRNA synthetase () encodes the enzyme that ligates threonine to tRNA in the cytoplasm. To date, variants have been implicated in a recessive brittle hair phenotype. To better understand -related recessive phenotypes, we engineered three missense mutations predicted to cause a loss-of-function effect and studied these variants in yeast and worm models. This revealed two loss-of-function mutations, including one hypomorphic allele (R433H). We next used R433H to study the effects of partial loss of function in a compound heterozygous mouse model (R433H/null). This model presents with phenotypes reminiscent of patients with variants and with distinct lung and skin defects. This study expands the potential clinical heterogeneity of -related recessive disease, which should guide future clinical and genetic evaluations of patient populations.
氨酰 - tRNA合成酶(ARSs)是普遍表达的必需酶,它们完成蛋白质翻译的第一步:将氨基酸连接到同源tRNA上。编码ARSs的基因与多种显性和隐性表型有关,后者通常影响多个组织,但中枢和外周神经系统、肝脏和肺经常受累。苏氨酰 - tRNA合成酶()编码在细胞质中将苏氨酸连接到tRNA的酶。迄今为止,已发现变体与隐性脆发表型有关。为了更好地理解与相关的隐性表型,我们设计了三个预测会导致功能丧失效应的错义突变,并在酵母和蠕虫模型中研究了这些变体。这揭示了两个功能丧失突变,包括一个亚效等位基因(R433H)。接下来,我们使用R433H在复合杂合小鼠模型(R433H/null)中研究功能部分丧失的影响。该模型呈现出与变体患者相似的表型以及明显的肺部和皮肤缺陷。这项研究扩展了与相关隐性疾病的潜在临床异质性,这应该指导未来对患者群体的临床和基因评估。